Search clinical trials for: Hormone refractory prostatic cancer
Total 132700 results
-
The Methodist Hospital Research InstituteOxford BioMedicaTerminatedProstatic NeoplasmsUnited States
-
The Methodist Hospital Research InstituteCellular TherapeuticsCompleted
-
The Methodist Hospital Research InstituteBayerTerminatedProstatic NeoplasmsUnited States
-
The Methodist Hospital Research InstituteOxford BioMedicaCompletedProstatic NeoplasmsUnited States
-
AHS Cancer Control AlbertaCross Cancer InstituteCompletedProstatic Neoplasms | Neoplasm Metastasis | Palliative CareCanada
-
Eisai Inc.CompletedProstate CancerFrance, United States, Romania, Canada, Peru, Brazil, Russian Federation, Chile, Croatia
-
Janssen PharmaceuticaWithdrawn
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)Completed
-
University of Wisconsin, MadisonProgen PharmaceuticalsTerminatedProstate CancerUnited States
-
Cantonal Hospital of St. GallenCompleted
-
Astellas Pharma IncCompletedProstate Cancer | TumorsUnited States
-
AmpliMed CorporationCompletedBreast Cancer | Prostate Cancer | Non-small Cell Lung CancerUnited States
-
Beth Israel Deaconess Medical CenterM.D. Anderson Cancer Center; Massachusetts General Hospital; Sunnybrook Health... and other collaboratorsCompletedProstate CancerUnited States, Canada
-
University of KentuckyOrtho Biotech, Inc.TerminatedProstate CancerUnited States
-
NovartisSocietà Italiana di Urologia (SIU)Completed
-
AmgenCompletedCastrate-resistant Prostate CancerUnited Kingdom, Czech Republic
-
Genzyme, a Sanofi CompanyCompletedHormone-refractory Prostate CancerUnited States
-
Daniel George, MDNovartis PharmaceuticalsCompletedHormone Refractory Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterNovartis; Aventis PharmaceuticalsCompletedHormone-Refractory Prostate CancerUnited States
-
University of Michigan Rogel Cancer CenterGlaxoSmithKlineCompletedProstate CancerUnited States
-
SanofiCompletedProstate Cancer MetastaticAustralia, Austria, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czech Republic, Denmark, Finland, Hungary, India, Ireland, Italy, Kazakhstan, Luxembourg, Malaysia, Mexico, Philippines, Poland, Portugal, Romania, Serbia, Singapo... and more
-
University of Michigan Rogel Cancer CenterCompleted
-
Mirati Therapeutics Inc.TerminatedStomach Cancer | Breast Cancer | Gastric Cancer | Lung Cancer | Prostate Cancer | Non-Small-Cell Lung Carcinoma | Prostatic Cancer | Pulmonary CancerUnited States
-
SanofiCompleted
-
Bostwick LaboratoriesProstate Institute of America; Community Memorial HealthCenter; HemaCare CorporationTerminated
-
Duke UniversityBristol-Myers SquibbTerminatedProstate CancerUnited States
-
Sandy SrinivasWyeth is now a wholly owned subsidiary of Pfizer; American Society of Clinical... and other collaboratorsTerminatedProstatic Neoplasms | Prostate Cancer | Metastatic Disease | Hormone-refractory Prostate Cancer | Castrate-resistant Prostate Cancer (CRPC) | Androgen-insensitive Prostate CancerUnited States
-
Bristol-Myers SquibbCompletedNeoplasm Metastasis | Prostate CancerUnited States
-
Centocor, Inc.TerminatedCancer, ProstateUnited States, United Kingdom, Belgium, Germany, Spain, France, Austria
-
Stanford UniversityAstraZenecaCompletedProstatic Neoplasms | Prostate CancerUnited States
-
Tianjin Medical University Cancer Institute and...UnknownHormone Refractory Prostate CancerChina
-
Boehringer IngelheimCompleted
-
BayerNo longer availableProstatic NeoplasmsUnited States
-
Eisai Inc.Completed
-
BayerCompletedNeoplasm Metastasis | Prostate CancerSweden, United Kingdom
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate Cancer | Hormone-refractory Prostate CancerUnited States
-
Nerviano Medical SciencesCompletedMetastatic Hormone Refractory Prostate CancerItaly
-
Centocor, Inc.CompletedProstatic NeoplasmsUnited States
-
University of Southern CaliforniaAventis PharmaceuticalsCompletedProstate AdenocarcinomaUnited States
-
Astellas Pharma IncAgensys, Inc.CompletedProstate CancerUnited States
-
Janssen Research & Development, LLCCompletedProstate NeoplasmsUnited States
-
CytoVac A/SCompletedHormone-refractory Prostate CancerDenmark
-
Bristol-Myers SquibbCompletedMetastatic Prostate CancerUnited States
-
Cougar Biotechnology, Inc.CompletedProstatic NeoplasmsUnited Kingdom
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedRecurrent Prostate Cancer | Hormone-resistant Prostate CancerUnited States
-
INSYS Therapeutics IncNational Cancer Institute (NCI)Completed
-
AmgenCompletedBone Metastases in Men With Hormone-Refractory Prostate Cancer | Bone Metastases in Subjects With Advanced Breast Cancer | Bone Metastases in Subjects With Advanced Cancer or Multiple MyelomaUnited Kingdom, Czech Republic
-
Cortice Biosciences, Inc.TerminatedProstate CancerUnited States
-
Jonsson Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownKidney Cancer | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Prostate Cancer | Multiple Myeloma and Plasma Cell Neoplasm
-
Duke UniversityUnited States Department of DefenseCompletedMetastatic Hormone Refractory Prostate CancerUnited States